New in this edition:* Third-generation antipsychotics with major additions and changes* Pharmacogenomics fully revised* ECT thoroughly revised and updated* BLT / rTMS with extended references* Extrapyramidal side effects chart extended* Antidepressants vilazodone and vortioxetine with extended coverage* Updated chart for switching antidepressants* New chart of agents under investigation for treatment of substanceuse disorders* Approved and off-label...